QPS检测方法检索器
经验证的检测方法
目前用于药代动力学、药效学和免疫原性的现代生物分析方法大部分基于LC-MS/MS和免疫分析方法。 但是，对于少量重要化合物，用这些技术进行生物分析不尽人意。 一个很好的替代方法是电感耦合等离子体质谱(ICP-MS)。 在ICP-MS中，样本被电感耦合等离子体离子化（离子化源），并使用质谱仪作为分离和检测目标离子的方法。
QPS检测列表含有多种经验证的检测方法，可满足您的全部分析需求。
QPS检测列表含有多种经验证的检测方法，可满足您的全部分析需求。
点击此处搜索检测方法！
Alfuzosin
| Matrix: | Human Plasma |
| Assay Range: | 0.05 - 50 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Cardiovascular |
| Classification: | Drug Assays |
Alkaline Phosphatase
| Matrix: | Human Urine |
| Assay Range: | 4.17 - 41.7 mU/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -20 |
| Platform: | Colorimetric |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Biochemical Biomarkers |
Alogliptin
| Matrix: | Human Plasma |
| Assay Range: | 0.75 - 200 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Anti-diabetic |
| Classification: | Drug Assays |
Alosetron
| Matrix: | Human Plasma |
| Assay Range: | 0.01 - 10 ng/mL |
| Sample Volume: | 0.3 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Diarrhea |
| Classification: | Drug Assays |
Alprazolam
| Matrix: | Human Plasma |
| Assay Range: | 1 - 50 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Anti-Anxiety |
| Classification: | Drug Assays |
Alprazolamα-Hydroxy Alprazolam
| Matrix: | Human Plasma |
| Assay Range: | 0.0500 - 25.0 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -20 |
| Platform: | LC-MS/MS |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | Anti-Anxiety |
| Classification: | Drug Assays |
Aluminium
| Matrix: | Formulation |
| Assay Range: | 1.00 - 100 µg/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | R.T. |
| Platform: | ICP-MS |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | Indigestion |
| Classification: | Drug Assays |
Aluminium
| Matrix: | Rat Faeces |
| Assay Range: | 49.9 - 2,017 ng/mg |
| Sample Volume: | 0.25 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -20 |
| Platform: | ICP-MS |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | Indigestion |
| Classification: | Drug Assays |
Aluminium
| Matrix: | Rat Urine |
| Assay Range: | 10.0 - 10,000 ng/mL |
| Sample Volume: | 0.25 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -20 |
| Platform: | ICP-MS |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | Indigestion |
| Classification: | Drug Assays |
Aluminium Zinc (total)
| Matrix: | Formulation |
| Assay Range: | 40.0 - 5,120 ng/mL for Aluminium (+ KCl)1.00 - 128 ng/mL for Aluminium (- KCl)40.0 - 2,560 ng/mL for Zinc (+ KCl)1.00 - 128 ng/mL for Zinc (- KCl) |
| Sample Volume: | 2 mL (non acid)0.02 mL (acid) |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | 2 - 8 |
| Platform: | ICP-MS |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | Indigestion |
| Classification: | Drug Assays |
Ambroxol
| Matrix: | Human Plasma |
| Assay Range: | 1 - 200 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Taiwan |
| CLIA: | No |
| Therapy Area: | Respiratory |
| Classification: | Drug Assays |
Amisulpride
| Matrix: | Human Plasma |
| Assay Range: | 10 - 3,000 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Taiwan |
| CLIA: | No |
| Therapy Area: | Antiemetic and Antipsychotic |
| Classification: | Drug Assays |
Amlodipine
| Matrix: | Human Plasma |
| Assay Range: | 25 - 5,000 pg/mL |
| Sample Volume: | 0.3 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Taiwan |
| CLIA: | No |
| Therapy Area: | Cardiovascular |
| Classification: | Drug Assays |
Amlodipine
| Matrix: | Human Plasma |
| Assay Range: | 0.05 - 5 ng/mL |
| Sample Volume: | 0.5 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Cardiovascular |
| Classification: | Drug Assays |
Amlodipine
| Matrix: | Human Plasma |
| Assay Range: | 0.05 - 10 ng/mL |
| Sample Volume: | 0.3 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Taiwan |
| CLIA: | No |
| Therapy Area: | Cardiovascular |
| Classification: | Drug Assays |
Amlodipine Telmisartan
| Matrix: | Human Plasma |
| Assay Range: | 0.1 - 14 ng/mL 3 - 1500 ng/mL |
| Sample Volume: | 0.3 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Cardiovascular |
| Classification: | Drug Assays |
Amoxicillin
| Matrix: | Human Plasma |
| Assay Range: | 200 - 20,000 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Antibiotic |
| Classification: | Drug Assays |
Amphetamine
| Matrix: | Human Plasma |
| Assay Range: | 0.1 - 100 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Stimulant |
| Classification: | Drug Assays |
Amphetamine
| Matrix: | Human Plasma |
| Assay Range: | 0.1 to 100 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | K2 EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Stimulant |
| Classification: | Drug Assays |
Amprenavir (APV)
| Matrix: | Human Plasma |
| Assay Range: | 100 - 10,000 ng/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Antiviral - HIV |
| Classification: | Drug Assays |
Amprenavir (APV)
Indinavir (IDV)
Nelfinavir (NFV)
Saquinavir (SQV)
Indinavir (IDV)
Nelfinavir (NFV)
Saquinavir (SQV)
| Matrix: | Human Plasma |
| Assay Range: | 1 - 1,000 ng/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Antiviral - HIV |
| Classification: | Drug Assays |
Anastrozole
| Matrix: | Human Plasma |
| Assay Range: | 0.1 - 20 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Oncology |
| Classification: | Drug Assays |
Anastrozole
| Matrix: | Human Plasma |
| Assay Range: | 0.1 - 25 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Taiwan |
| CLIA: | No |
| Therapy Area: | Oncology |
| Classification: | Drug Assays |
Apixaban
| Matrix: | Human Plasma |
| Assay Range: | 1.3 - 400 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Cardiovascular |
| Classification: | Drug Assays |
Apolipoprotein E (ApoE) (112T>C, 158C>T) Genotyping
| Matrix: | Human Whole Blood |
| Assay Range: | N/A |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -80 |
| Platform: | Pyrosequencing |
| Site: | QPS-Delaware |
| CLIA: | Yes |
| Therapy Area: | Alzheimer's Disease |
| Classification: | Genomic Biomarkers |
点击此处下载免费的APPLE或ANDROID APP！
